FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used for treatment of vascular depression. For this purpose efficient amount of cholinesterase inhibitors is introduced.
EFFECT: in addition to improvement of cognitive and executive functions method ensures reduction of depression symptoms in patients with cerebrovascular disorders.
32 cl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED MEDICATION FOR WEIGHT-REDUCING TREATMENT | 2004 |
|
RU2363458C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2785871C2 |
| ORGANIC COMPOUNDS | 2015 |
|
RU2728787C2 |
| COMPOSITION WHICH CONTAINS VIRUS-LIKE PARTICLE (VLP) AND AMYLOID-BETA PEPTIDE | 2005 |
|
RU2415677C2 |
| APPLICATION OF CARBAMAZEPINE DERIVATIVES FOR TREATING EXCITATION IN PATIENTS SUFFERING FROM DEMENTIA | 2004 |
|
RU2351338C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM | 2006 |
|
RU2450805C2 |
| DPP-IV INHIBITORS FOR TREATMENT OF NEURODEGENERATION AND COGNITIVE DISORDERS | 2005 |
|
RU2394570C2 |
| METHYLTHIONINIUM FOR TREATING SYNAPTOPATHIES | 2020 |
|
RU2835868C2 |
| MIRTAZAPINE-CONTAINING ORALLY DECOMPOSING COMPOSITION | 2000 |
|
RU2261098C2 |
| COMPOSITIONS CONTAINING MONOAMINE REUPTAKE INHIBITOR AND METHODS OF THEIR APPLICATION | 2004 |
|
RU2358719C2 |
